Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
A Multi-center, Randomized-controlled, Open-label Clinical Trial: Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Listed as NCT03108560, this NA trial focuses on Carcinoma, Non-Small-Cell Lung and remains ongoing. Sponsored by First Affiliated Hospital of Wenzhou Medical University, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2024 [monthly]
Recruiting NA
-
Dec 2018 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Oct 2018 — Dec 2018 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Wenzhou Medical University
- Fujian Medical University Union Hospital
- Ningbo No.2 Hospital
- RenJi Hospital
- Ruijin Hospital
- Shanghai Zhongshan Hospital
- The Second Affiliated Hospital of Dalian Medical University
For direct contact, visit the study record on ClinicalTrials.gov .